Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
USAGAINSTALZHEIMER'S ACTION via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Source: Senate LDA
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS |
| 50 |
| 2011–2023 |
| NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION | 50 | 2006–2018 |
| AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION (AOPA) | 48 | 2007–2023 |
| HEALTH SOUTH CORPORATION | 48 | 2005–2017 |
| HOLOGIC, INC. | 48 | 2015–2026 |
| VISION SERVICE PLAN | 45 | 2007–2017 |
| GREATER NEW YORK HOSPITAL ASSOCIATION | 43 | 2009–2020 |
| SOCIETY OF INTERVENTIONAL RADIOLOGY | 42 | 2009–2024 |
| TRAVERE THERAPEUTICS | 42 | 2016–2026 |
| THE METROHEALTH SYSTEM | 33 | 2018–2026 |
| TIVITY HEALTH, INC. | 31 | 2017–2024 |
| AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS | 30 | 2017–2024 |
| CELGENE CORPORATION | 26 | 2009–2015 |
| DEVOTED HEALTH | 26 | 2020–2026 |
| EYECARE PARTNERS LLC | 24 | 2020–2025 |
| ENDO PHARMACEUTICALS | 23 | 2006–2014 |
| REHABILITATION INSTITUTE OF CHICAGO | 22 | 2010–2015 |
| IOWA DONOR NETWORK | 19 | 2021–2026 |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | 18 | 2020–2024 |
| AMERICAN ASSOCIATION OF NURSE ANESTHETISTS | 17 | 2006–2017 |
| HEARING INDUSTRIES ASSOCIATION | 17 | 2009–2016 |
| MYLAN LABORATORIES | 17 | 2006–2011 |
| AETNA, INC. | 16 | 2012–2015 |
| AMERICAN AMBULANCE ASSOCIATION | 15 | 2022–2025 |
| CVS CAREMARK INC (FORMERLY CAREMARK RX INC ) | 15 | 2007–2012 |
| HEALTHWAYS | 15 | 2015–2018 |
| HOSPITAL ASSOCIATION OF OREGON | 15 | 2023–2026 |
| ALABAMA HOSPITAL ASSOCIATION | 14 | 2021–2024 |
| AMERICAN HEALTH QUALITY ASSOCIATION | 13 | 2011–2014 |
| REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS | 13 | 2023–2026 |
| AMERICAN COLLEGE OF LIFESTYLE MEDICINE | 12 | 2019–2021 |
| IOWA HOSPITAL ASSOCIATION | 12 | 2020–2022 |
| THE NRP GROUP LLC | 12 | 2020–2022 |
| EMD SERONO, INC. | 11 | 2010–2013 |
| FLOW THERAPY | 11 | 2019–2022 |
| GENERIC PHARMACEUTICAL ASSOCIATION | 11 | 2007–2010 |
| NOVARTIS CORPORATION | 11 | 2017–2020 |
| TRISALUS LIFE SCIENCES | 11 | 2021–2024 |
| FUTURE OF PHARMACY COALITION LLC | 10 | 2023–2025 |
| SMALL BUSINESS CIGAR COALITION (INFORMAL COALITION) | 10 | 2013–2015 |
| ABBOTT LABORATORIES | 9 | 2006–2009 |
| AFLAC INC | 9 | 2023–2025 |
| LIFESCAN, INC. | 9 | 2006–2009 |
| ROCHE DIAGNOSTICS | 9 | 2006–2009 |
| BAYER HEALTHCARE | 8 | 2006–2009 |
| BOSTON SCIENTIFIC CORPORATION | 8 | 2025–2026 |
| CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 8 | 2025–2026 |
| COUNCIL OF STATE ADMINISTRATORS OF VOCATIONAL REHABILITATION ("CSAVR") | 8 | 2006–2014 |
| HEALTH MANAGEMENT ASSOCIATES | 8 | 2006–2014 |
| NATIONAL BRAIN TUMOR SOCIETY | 8 | 2024–2026 |
| THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH | 8 | 2025–2026 |
| ACADEMY OF GENERAL DENTISTRY | 7 | 2023–2024 |
| ADVANCED OXYGEN THERAPY INC. (AOTI) | 7 | 2023–2026 |
| AMERICAN MEDICAL REHABILITATION PROVIDERS ASSOCIATION | 7 | 2024–2026 |
| APPRISE HEALTH INSIGHTS | 7 | 2024–2025 |
| BIOMERIEUX, INC. | 7 | 2025–2026 |
| KERECIS | 7 | 2025–2026 |
| OREGON HEALTH & SCIENCE UNIVERSITY | 7 | 2025–2026 |
| USHEALTH GROUP, INC. | 7 | 2017–2018 |
| CAREFUSION | 6 | 2010–2011 |
| DEY, L.P. | 6 | 2009 |
| KIDNEY CARE COUNCIL | 6 | 2005–2008 |
| VIANT HEALTH PAYMENT SOLUTIONS | 6 | 2007–2008 |
| ALLIANCE FOR QUALITY NURSING HOME CARE | 5 | 2006–2007 |
| COHERUS BIOSCIENCES, INC | 5 | 2023–2024 |
| CONFLUENT HEALTH | 5 | 2025 |
| EYECARE COALITION (INFORMAL COALITION) | 5 | 2020–2021 |
| OSSIUM HEALTH, INC. | 5 | 2025–2026 |
| OUTSET MEDICAL | 5 | 2023 |
| AGENDIA, INC. | 4 | 2025–2026 |
| AMERICAN ASSOCIATION OF HIP AND KNEE SURGEONS | 4 | 2012–2013 |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 4 | 2019–2020 |
| COALITION OF FULL SERVICE COMMUNITY HOSPITALS | 4 | 2007–2008 |
| NATIONAL ASSOCIATION FOR BEHAVIORAL HEALTH | 4 | 2008–2009 |
| US ONCOLOGY INC | 4 | 2006–2008 |
| APHENA PHARMA SOLUTIONS | 3 | 2013 |
| ATHENAHEALTH | 3 | 2012 |
| CERVIVOR | 3 | 2018 |
| CONOCOPHILLIPS | 3 | 2023 |
| INMAR | 3 | 2020 |
| LEADINGAGE, INC. | 3 | 2015 |
| MARINE POLYMER TECHNOLOGIES | 3 | 2006–2007 |
| MASSACHUSETTS HOSPITAL ASSOCIATION | 3 | 2006–2007 |
| NATIONSHEALTH | 3 | 2010–2011 |
| ONCOSEC MEDICAL INCORPORATED | 3 | 2020 |
| PACKAGING COORDINATORS, INC. | 3 | 2013 |
| PHARMA PACKAGING SOLUTIONS | 3 | 2013 |
| S ROTHSCHILD & CO INC | 3 | 2007–2008 |
| USAGAINSTALZHEIMER'S ACTION | 3 | 2026 |
| CROWN LABORATORIES, INC. | 2 | 2017 |
| Chemed Corporation | 2 | 2007–2008 |
| DERMATOLOGY COALITION (INFORMAL COALITION) | 2 | 2026 |
| EDUCAP, INC. | 2 | 2007 |
| FRESENIUS MEDICAL CARE | 2 | 2007 |
H.R.10571, Surge to Save Newborns Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improve and Enhance the Work Opportunity Tax Credit Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Mikaela Naylon Give Kids a Chance Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act. Importance of patient voice in rare kidney disease.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
New Era of Preventing End-Stage Kidney Disease Act
Client: TRAVERE THERAPEUTICS · Firm: ALSTON & BIRD LLP
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
Ensuring Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer. Office of Management and Budget's Proposed Rule on Uniform Guidance/Uniform Grants Regulation.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. 340b price transparency issues concerning 340B program rebate proposal. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Payment and regulation of clinical laboratory tests. H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Support for protecting front line multimission hospitals. Congressionally directed spending request in the Labor-HHS Appropriations bill for capital funding for Emergency Department renovation. H.R.5371, the Continuing Appropriations and Extensions Act, 2026.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer. Office of Management and Budget's Proposed Rule on Uniform Guidance/Uniform Grants Regulation.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Main Street Tax Certainty Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Main Street Tax Certainty Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Main Street Tax Certainty Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Main Street Tax Certainty Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Provider Reimbursement Stability Act of 2026
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Medicare Advantage Improvement Act of 2026
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Medicare Advantage Improvement Act of 2026
Client: AMERICAN MEDICAL REHABILITATION PROVIDERS ASSOCIATION · Firm: ALSTON & BIRD LLP
Medicare reimbursement issues. H.R.8375/S.4384, Medicare Advantage Improvement Act of 2026.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals. PDUFA/regulatory review process.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals. PDUFA/regulatory review process.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals. PDUFA/regulatory review process.
Patients First Act of 2026
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Travel Trailer and Camper Tax Parity Act
Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS · Firm: ALSTON & BIRD LLP
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Improving Seniors’ Timely Access to Care Act of 2025
Client: AMERICAN COLLEGE OF GASTROENTEROLOGY · Firm: ALSTON & BIRD LLP
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer. Office of Management and Budget's Proposed Rule on Uniform Guidance/Uniform Grants Regulation.
Patients Deserve Price Tags Act
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S.2355, Patients Deserve Price Tags Act. Prior Authorization.
Patients Deserve Price Tags Act
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S.2355, Patients Deserve Price Tags Act.
Equitable Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Payment and regulation of clinical laboratory tests. H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2026 · third_quarter · Q3
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit.
Treatment of orphan drugs under tariff proposals.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals. PDUFA/regulatory review process.
H.R.10571, Surge to Save Newborns Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. 340b price transparency issues concerning 340B program rebate proposal. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
Support for protecting front line multimission hospitals.
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Medicare Advantage issues; Health Care Reimbursement; Home health long-term care issues as it relates to health care reform implementation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OSSIUM HEALTH, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Advancing contract and other partnership opportunities for Ossium.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
OREGON HEALTH & SCIENCE UNIVERSITY via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to academic medicine and research.
Issues related to academic medicine and research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL BRAIN TUMOR SOCIETY via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.
General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IOWA DONOR NETWORK via ALSTON & BIRD LLP
2026 · third_quarter · Q3
General Medicare and Medicaid issues. Organ donation and transplantation issues.
General Medicare and Medicaid issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMPULSE DYNAMICS USA via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Medicare reimbursement for medical device.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HOSPITAL ASSOCIATION OF OREGON via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to global women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI. FY2027 Appropriations bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
DEVOTED HEALTH via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to Medicare Advantage Health Plan.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DERMATOLOGY COALITION (INFORMAL COALITION) via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Medicare payment issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Over-the-counter user fee reauthorization; expansion of health savings accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues concerning Medicare reimbursement, AI and medical technology.
Advocacy concerning tax issues.
Advocacy concerning trade issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Funding for colorectal cancer screening and education. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. Screening concerns per younger incidence colorectal cancer. Office of Management and Budget's Proposed Rule on Uniform Guidance/Uniform Grants Regulation.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer. Office of Management and Budget's Proposed Rule on Uniform Guidance/Uniform Grants Regulation.
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2026 · third_quarter · Q3
S.2355, Patients Deserve Price Tags Act. Prior Authorization.
Payment and regulation of clinical laboratory tests. H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ADVANCED OXYGEN THERAPY INC. (AOTI) via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Medicare coverage issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
DERMATOLOGY COALITION (INFORMAL COALITION) via ALSTON & BIRD LLP
2026 · third_quarter · RR
Medicare payment issues.
USAGAINSTALZHEIMER'S ACTION via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2026 · second_quarter · Q2
The Newborn Screening Reauthorization Act, and improving funding of newborn screening implementation; Importance of patient voice in rare kidney disease.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals. PDUFA/regulatory review process.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit.
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2026 · second_quarter · Q2
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Medicare Advantage issues; Health Care Reimbursement; Home health long-term care issues as it relates to health care reform implementation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OSSIUM HEALTH, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Advancing contract and other partnership opportunities for Ossium.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
OREGON HEALTH & SCIENCE UNIVERSITY via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to academic medicine and research.
Issues related to academic medicine and research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL BRAIN TUMOR SOCIETY via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.
General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IOWA DONOR NETWORK via ALSTON & BIRD LLP
2026 · second_quarter · Q2
General Medicare and Medicaid issues. Organ donation and transplantation issues.
General Medicare and Medicaid issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL ASSOCIATION OF OREGON via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to global women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI. FY2027 Appropriations bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
DEVOTED HEALTH via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to Medicare Advantage Health Plan.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Over-the-counter user fee reauthorization; expansion of health savings accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Advocacy concerning tax issues.
Issues concerning Medicare reimbursement, AI and medical technology.
Advocacy concerning trade issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL REHABILITATION PROVIDERS ASSOCIATION via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Medicare reimbursement issues. H.R.8375/S.4384, Medicare Advantage Improvement Act of 2026.
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2026 · second_quarter · Q2
S.2355, Patients Deserve Price Tags Act.
Payment and regulation of clinical laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AGENDIA, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to Medicare coverage.
Issues related to Medicare coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADVANCED OXYGEN THERAPY INC. (AOTI) via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Medicare coverage issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
IMPULSE DYNAMICS USA via ALSTON & BIRD LLP
2026 · second_quarter · RR
Medicare reimbursement issues.
USAGAINSTALZHEIMER'S ACTION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Issues related to funding for Alzheimer's research, engaging with key lawmakers and agency officials in defense of NIH spending overall.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals. PDUFA/regulatory review process.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Support for protecting front line multimission hospitals. Congressionally directed spending request in the Labor-HHS Appropriations bill for capital funding for Emergency Department renovation. H.R.5371, the Continuing Appropriations and Extensions Act, 2026.
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Medicare Advantage issues; Health Care Reimbursement; Home health long-term care issues as it relates to health care reform implementation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Medicare Advantage issues; Health Care Reimbursement; Home health long-term care issues as it relates to health care reform implementation.
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OSSIUM HEALTH, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Advancing contract and other partnership opportunities for Ossium.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
OREGON HEALTH & SCIENCE UNIVERSITY via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to academic medicine and research.
Issues related to academic medicine and research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL COUNCIL FOR MENTAL WELLBEING via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues concerning behavioral health care reimbursement and funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL BRAIN TUMOR SOCIETY via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IOWA DONOR NETWORK via ALSTON & BIRD LLP
2026 · first_quarter · Q1
General Medicare and Medicaid issues. Organ donation and transplantation issues.
General Medicare and Medicaid issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL ASSOCIATION OF OREGON via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to global women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
DEVOTED HEALTH via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to Medicare Advantage Health Plan.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.
Discussions regarding tariff proposals.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2026 · first_quarter · Q1
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
Funding for colorectal cancer screening and education. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. Screening concerns per younger incidence colorectal cancer.
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Over-the-counter user fee reauthorization; expansion of health savings accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues concerning Medicare reimbursement, AI and medical technology.
Advocacy concerning trade issues.
Advocacy concerning tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL REHABILITATION PROVIDERS ASSOCIATION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Medicare reimbursement issues.
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Payment and regulation of clinical laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AGENDIA, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to Medicare coverage.
Issues related to Medicare coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Q1
General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.
General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2025 · first_quarter · 1A
Issues related to women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2025 · first_quarter · 1A
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation impacting products approved under the Accelerated Approval pathway. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Policies regarding copay accumulators and impact on rare disease patients.
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals.
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Medicare Advantage issues; Health Care Reimbursement; Home health long-term care issues as it relates to health care reform implementation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OSSIUM HEALTH, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Advancing contract and other partnership opportunities for Ossium.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
OREGON HEALTH & SCIENCE UNIVERSITY via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to academic medicine and research.
Issues related to academic medicine and research.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL BRAIN TUMOR SOCIETY via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
General health care issues related to Medicare coverage policies.
General health care issues related to Medicare coverage policies.
IOWA DONOR NETWORK via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
General Medicare and Medicaid issues.
General Medicare and Medicaid issues. Organ donation and transplantation issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL ASSOCIATION OF OREGON via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to global women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
EYECARE PARTNERS LLC via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Reimbursement issues for eye care industry.
Reimbursement issues for eye care industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEVOTED HEALTH via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to Medicare Advantage Health Plan.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Over-the-counter user fee reauthorization; expansion of health savings accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONFLUENT HEALTH via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Physician payment issues.
Physician payment issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON SCIENTIFIC CORPORATION via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues concerning Medicare reimbursement, AI and medical technology.
Advocacy concerning tax issues.
Advocacy concerning trade issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Pub. L. No. 119-21, One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
AMERICAN MEDICAL REHABILITATION PROVIDERS ASSOCIATION via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Medicare reimbursement issues.
Medicare reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform.
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025.
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Payment and regulation of clinical laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AGENDIA, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to Medicare coverage.
Issues related to Medicare coverage.
ADVANCED OXYGEN THERAPY INC. (AOTI) via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Medicare coverage issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
AGENDIA, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · RR
Issues related to Medicare coverage.
Issues related to Medicare coverage.
OSSIUM HEALTH, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · RR
Advancing contract and other partnership opportunities for Ossium.
TRAVERE THERAPEUTICS via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
THE METROHEALTH SYSTEM via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703/S.213, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Medicare Advantage issues; Health Care Reimbursement; Home health long-term care issues as it relates to health care reform implementation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OREGON HEALTH & SCIENCE UNIVERSITY via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues related to academic medicine and research.
Issues related to academic medicine and research.
Issues related to academic medicine and research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BRAIN TUMOR SOCIETY via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Q3
General health care issues related to Medicare coverage policies.
General health care issues related to Medicare coverage policies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL ASSOCIATION OF OREGON via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.
Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Discussions regarding tariff proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. General provisions to address Medicare physician fee schedule payment policies and access to physician services. In general, policies impacting physician burden and sustaining the private practice physician model. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicare physicians payment increase, reform. H.R.9693, Patients First Act. H.R.8163/S.5180, Provider Reimbursement Stability Act. H.R.8375/S.4384, Medicare Advantage Improvement Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support for protecting front line multimission hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Discussions regarding tariff proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for colorectal cancer screening and education. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. Screening concerns per younger incidence colorectal cancer.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act. Importance of patient voice in rare kidney disease.
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R.5509/S.2903, The Safe Step Act. Issues related to coverage of products under drug formulary. In general, policies reforming prior authorization of physician services. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act of 2025. Screening concerns per younger incidence colorectal cancer.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding orphan drug pricing, value, and reimbursement, relative to the Inflation Reduction Act of 2022 (Pub. L. No. 117-169, 136 Stat. 1818 (2022)). Policies regarding copay accumulators and impact on rare disease patients. Support of reauthorization of priority review voucher program. H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. Support of reauthorization of priority review voucher program.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Legislation to improve education and care pathways for patients with rare kidney disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support for protecting front line multimission hospitals. Congressionally directed spending request in the Labor-HHS Appropriations bill for capital funding for Emergency Department renovation. H.R.5371, the Continuing Appropriations and Extensions Act, 2026.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Discussions regarding tariff proposals.
Pub. L. No. 119-21, One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of U.S. Tax Code.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for colorectal cancer screening and education. In general, policies impacting physician burden and sustaining the private practice physician model. Center for Consumer Information and Insurance Oversight guidance on ACA preventive services and coverage of surveillance colonoscopy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals.
Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act.
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support for protecting front line multimission hospitals. Congressionally directed spending request in the Labor-HHS Appropriations bill for capital funding for Emergency Department renovation. H.R.5371, the Continuing Appropriations and Extensions Act, 2026.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE